[
  {
    "ts": null,
    "headline": "Bristol Myers Squibb : First Quarter 2025 Preliminary Q1 2025 Acquired IPRD & Licensing Income",
    "summary": "BRISTOL-MYERS SQUIBB COMPANY Preliminary Estimated First Quarter Impact of Acquired In-Process Research and Development and Licensing Income ...",
    "url": "https://finnhub.io/api/news?id=e7828ef2e2a3d459768935a93132fe6d0dbf5be08c98e31e52521a6933c0bbef",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743700662,
      "headline": "Bristol Myers Squibb : First Quarter 2025 Preliminary Q1 2025 Acquired IPRD & Licensing Income",
      "id": 133700100,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "BRISTOL-MYERS SQUIBB COMPANY Preliminary Estimated First Quarter Impact of Acquired In-Process Research and Development and Licensing Income ...",
      "url": "https://finnhub.io/api/news?id=e7828ef2e2a3d459768935a93132fe6d0dbf5be08c98e31e52521a6933c0bbef"
    }
  },
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog Highlights Exxon Mobil, Bristol-Myers Squibb, Chubb and Hamilton Beach Brands",
    "summary": "Exxon Mobil, Bristol-Myers Squibb, Chubb and Hamilton Beach Brands are part of the Zacks top Analyst Blog.",
    "url": "https://finnhub.io/api/news?id=f361c060b23499500b7935963008a187353dee77ce7034034b669317619ac195",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743691800,
      "headline": "The Zacks Analyst Blog Highlights Exxon Mobil, Bristol-Myers Squibb, Chubb and Hamilton Beach Brands",
      "id": 133698594,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Exxon Mobil, Bristol-Myers Squibb, Chubb and Hamilton Beach Brands are part of the Zacks top Analyst Blog.",
      "url": "https://finnhub.io/api/news?id=f361c060b23499500b7935963008a187353dee77ce7034034b669317619ac195"
    }
  },
  {
    "ts": null,
    "headline": "Pharma Stocks Aren't in the Clear, Despite Tariff Exemption—Heard on the Street",
    "summary": "Big pharmaceutical stocks mostly rose after President Trump’s executive order exempted medicines from new tariffs. Merck, Bristol-Myers Squibb, and Johnson & Johnson were among the top performers in the S&P 500, with the sector also benefiting from its status as a defensive play.",
    "url": "https://finnhub.io/api/news?id=dafc455d6b043cbaeb717724b5933eb6ce4e53e22c177f5a35f7c74bc43607e6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743690622,
      "headline": "Pharma Stocks Aren't in the Clear, Despite Tariff Exemption—Heard on the Street",
      "id": 133697704,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Big pharmaceutical stocks mostly rose after President Trump’s executive order exempted medicines from new tariffs. Merck, Bristol-Myers Squibb, and Johnson & Johnson were among the top performers in the S&P 500, with the sector also benefiting from its status as a defensive play.",
      "url": "https://finnhub.io/api/news?id=dafc455d6b043cbaeb717724b5933eb6ce4e53e22c177f5a35f7c74bc43607e6"
    }
  },
  {
    "ts": null,
    "headline": "Healthcare Stocks Are Steady Amid Tariff Rout. Stay Alert to the Dangers Ahead.",
    "summary": "Healthcare Stocks Are Steady Amid Tariff Rout. Stay Alert to the Dangers Ahead.",
    "url": "https://finnhub.io/api/news?id=d95fdde3fd50bbff5de7c5f5499f53cb7d22d5d58f79c94cf078f8675f0c129e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743682800,
      "headline": "Healthcare Stocks Are Steady Amid Tariff Rout. Stay Alert to the Dangers Ahead.",
      "id": 134150143,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Healthcare Stocks Are Steady Amid Tariff Rout. Stay Alert to the Dangers Ahead.",
      "url": "https://finnhub.io/api/news?id=d95fdde3fd50bbff5de7c5f5499f53cb7d22d5d58f79c94cf078f8675f0c129e"
    }
  }
]